权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The "Phoenix Rising" pathway of tumor repopulation during radiotherapy

放疗过程中肿瘤增殖的“凤凰涅槃”途径

基本信息

批准号：
8882304
负责人：
Chuan-Yuan Li
金额：
$ 32.58万
依托单位：
DUKE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-09-01 至 2017-07-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): More than 40 years ago, the phenomenon of "accelerated repopulation" was described in experimental tumors undergoing radiotherapy. Today, the concept of preventing tumor cellular repopulation during treatment is a basic tenet in radiotherapy. In fact, it is one of the four all-important "R"s widely taught in radiation oncology textbooks. However, the molecular mechanisms involved in tumor repopulation are still very poorly understood. In this project, we propose a paradigm changing hypothesis with regard to the molecular mechanism of tumor repopulation during radiotherapy. Our hypothesis is that dying cells are responsible for mobilizing and stimulating the surviving tumor cells to repopulate the irradiated tumor through paracrine signaling. Our hypothesis is based on our recent discovery of the "Phoenix Rising" pathway through which caspase 3 activates paracrine signaling cascades from dying cells to stimulate tissue regeneration and the rapid proliferation of surviving tumor cells in irradiated tumors. We plan to carry out the following in-depth investigations of the roles of caspases and other factors in the "Phoenix Rising" pathway in tumor response to radiotherapy (specific aim 1). In addition, we plan to examine the roles of downstream factors of caspases in the "Phoenix Pathway" (specific aim 2). Finally we will attempt to determine if inhibition of caspases or their downstream factors is a feasible strategy to enhance cancer radiotherapy (specific aim 3). We believe our project will provide crucial insights into how tumors relapse after radiotherapy. It also has the potential to facilitate the development of new therapeutics for enhancing cancer radiotherapy.

描述（申请人提供）：40多年前，在接受放射治疗的实验肿瘤中描述了“加速再生”现象。如今，在治疗过程中防止肿瘤细胞增殖的概念已成为放射治疗的基本原则。事实上，它是放射肿瘤学教科书中广泛教授的四个最重要的“R”之一。然而，人们对肿瘤再增殖的分子机制仍然知之甚少。在这个项目中，我们提出了关于放疗期间肿瘤再增殖的分子机制的范式改变假设。我们的假设是，垂死的细胞负责动员和刺激存活的肿瘤细胞，通过旁分泌信号重新填充受辐射的肿瘤。我们的假设基于我们最近发现的“凤凰崛起”途径，通过该途径，Caspase 3 激活垂死细胞的旁分泌信号级联，刺激组织再生和受辐射肿瘤中存活肿瘤细胞的快速增殖。我们计划针对“凤凰涅槃”通路中caspases等因子在肿瘤放疗反应中的作用开展以下深入研究（具体目标1）。此外，我们计划研究caspase下游因子在“凤凰通路”中的作用（具体目标2）。最后，我们将尝试确定抑制半胱天冬酶或其下游因子是否是增强癌症放射治疗的可行策略（具体目标 3）。我们相信我们的项目将为放射治疗后肿瘤如何复发提供重要的见解。它还具有促进开发新疗法以增强癌症放射治疗的潜力。